Sierra Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sierra Capital’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$334K	Hold	12,636	–	–	0.04%	189
2025 Q4	$366K	Hold	12,636	–	–	0.04%	172
2025 Q3	$351K	Hold	12,636	–	–	0.04%	185
2025 Q2	$308K	Hold	12,636	–	–	0.04%	187
2025 Q1	$262K	Hold	12,636	–	–	0.03%	178
2024 Q4	$298K	Sell	12,636 -6,035	-32%	-$149K	0.04%	170
2024 Q3	$478K	Hold	18,671	–	–	0.06%	162
2024 Q2	$438K	Hold	18,671	–	–	0.06%	154
2024 Q1	$537K	Hold	18,671	–	–	0.07%	148
2023 Q4	$613K	Hold	18,671	–	–	0.09%	133
2023 Q3	$520K	Hold	18,671	–	–	0.08%	136
2023 Q2	$636K	Sell	18,671 -3,680	-16%	-$116K	0.1%	127
2023 Q1	$672K	Sell	22,351 -57,875	-72%	-$1.79M	0.11%	121
2022 Q4	$2.27M	Buy	80,226 +14,669	+22%	+$466K	0.39%	59
2022 Q3	$2.15M	Hold	65,557	–	–	0.4%	58
2022 Q2	$2.06M	Buy	65,557 +35,499	+118%	+$1.24M	0.37%	61
2022 Q1	$1.38M	Hold	30,058	–	–	0.22%	96
2021 Q4	$1.84M	Hold	30,058	–	–	0.27%	82
2021 Q3	$2.26M	Hold	30,058	–	–	0.38%	67
2021 Q2	$2.78M	Buy	+30,058	New	+$2.56M	0.52%	55

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sierra Capital's ARKG Position: Q1 2026 in Review

Sierra Capital held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 12,636 shares worth $334K. The position accounts for 0.04% of the portfolio, ranked #189.

Sierra Capital first reported a position in ARKG in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.78M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Sierra Capital held 12,636 shares of ARK Genomic Revolution ETF worth $334K as of Q1 2026.
Sierra Capital left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
ARK Genomic Revolution ETF made up 0.04% of Sierra Capital's portfolio in Q1 2026, its #189 holding.
Sierra Capital first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 20 quarters since.
Sierra Capital's ARK Genomic Revolution ETF position peaked at $2.78M in Q2 2021.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Sierra Capital's 13F filing for Q1 2026, filed 15 May 2026.